Surgical Management of Thyrotropin-Secreting Pituitary Adenomas

Pituitary

Volumn 2, Issue 2, 1999, Pages 127-131

  Losa, Marco ^a,b   Mortini, Pietro ^a   Franzin, Alberto ^a   Barzaghi, Raffaella ^a   Mandelli, Carlo ^a   Giovanelli, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Pituitary neoplasm; Pituitary surgery; TSH

Indexed keywords

THYROID HORMONE; THYROTROPIN;

ADENOMA; ARTICLE; DIFFERENTIAL DIAGNOSIS; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOPHYSIS TUMOR; METABOLISM; PHYSIOLOGY; SECRETION; TREATMENT OUTCOME;

ADENOMA; DIAGNOSIS, DIFFERENTIAL; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; PITUITARY NEOPLASMS; THYROID HORMONES; THYROTROPIN; TREATMENT OUTCOME;

EID: 0033170940     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009987530852     Document Type: Article

References (16)

1. Beck-Peccoz P, Persani L. Thyrotropin (TSH)-secreting pituitary tumors: endocrinology, clinical aspects and treatment. In: Landolt AM, Vance ML, Reilly PL, eds. Pituitary Adenomas: Biology, Diagnosis and Treatment. London: Churchill Livingstone, 1996;139-155.
2. Ambrosi B, Faglia G, and the Multicenter Pituitary Tumor Study Group, Lombardia Region. Epidemiology of pituitary tumors. In: Faglia G, Beck-Peccoz P, Ambrosi A, Travaglini P, Spada A, eds. Pituitary Adenomas: New Trends in Basic and Clinical Research. Amsterdam: Excerpta Medica, 1991;159-168.
3. Mindermann T, Wilson CB. Thyrotropin-producing pituitary adenomas. J Neurosurg 1993;79:521-527.
4. Smallridge RC. Thyrotropin-secreting pituitary tumors. Endocrinol Metab Clin 1987;16:765-792.
5. Refetoff S, Weiss RE, Usala SJ. The syndromes of resistance to thyroid hormone. Endocr Rev 1993;14:348-399.
6. Beck-Peccoz P, Chatterjee VKK. The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 1994;4:225-232.
7. Beck-Peccoz P, Roncoroni R, Mariotti S, et al. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): Evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST. J Clin Endocrinol Metab 1990;71:19-25.
8. Watanabe K, Kameya T, Yamauchi A, et al. Thyrotropin producing adenoma associated with pituitary resistance to thyroid hormone. J Clin Endocrinol Metab 1993;76: 1025-1030.
9. Hill SA, Falko JM, Wilson CB, Hunt WE. Thyrotrophin-producing pituitary adenomas. J Neurosurg 1982;57:515-519.
10. Grisoli F, Leclercq T, Winteler JP, et al. Thyroid-stimulating pituitary adenomas and hyperthyroidism. Surg Neurol 1986;25:361-368.
11. McCutcheon IE, Weintraub BD, Oldfield EH. Surgical treatment of thyrotropin-secreting pituitary adenomas. J Neurosurg 1990;73:674-683.
12. Beckers A, Abs R, Mahler C, Vandalem JL, Pirens G, Hennen G, Stevenaert A. Thyrotropin-secreting pituitary adenomas: Report of seven cases. J Clin Endocrinol Metab 1991;72:477-483.
13. Losa M, Giovanelli M, Persani L, Mortini P, Faglia G, Beck-Peccoz P. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 1996;81:3084-3090.
14. Bertherat J, Brue T, Enjalbert A, et al. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: Comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions. J Clin Endocrinol Metab 1992;75:540-546.
15. Losa M, Magnani P, Mortini P, et al. Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: Correlation with the effect of a single administration of octreotide on serum TSH levels. Eur J Nucl Med 1997;24:728-731.
16. Gancel A, Vuillermet P, Legrand A, Catus F, Thomas F, Kuhn JM. Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas. Clin Endocrinol (Oxf) 1994;40:421-428.